These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7753374)

  • 21. Intrastriatal implantation of interleukin-1. Reduction of parkinsonism in rats by enhancing neuronal sprouting from residual dopaminergic neurons in the ventral tegmental area of the midbrain.
    Wang J; Bankiewicz KS; Plunkett RJ; Oldfield EH
    J Neurosurg; 1994 Mar; 80(3):484-90. PubMed ID: 7906726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Morphine increases the activity of midbrain dopamine neurons in vitro.
    Trulson ME; Arasteh K
    Eur J Pharmacol; 1985 Aug; 114(1):105-9. PubMed ID: 2931290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synaptic innervation of midbrain dopaminergic neurons by glutamate-enriched terminals in the squirrel monkey.
    Smith Y; Charara A; Parent A
    J Comp Neurol; 1996 Jan; 364(2):231-53. PubMed ID: 8788247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cytology of dopaminergic and nondopaminergic neurons in the substantia nigra and ventral tegmental area of the rat: a light- and electron-microscopic study.
    Domesick VB; Stinus L; Paskevich PA
    Neuroscience; 1983 Apr; 8(4):743-65. PubMed ID: 6408498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. D-amphetamine-induced behavioral sensitization: implication of a glutamatergic medial prefrontal cortex-ventral tegmental area innervation.
    Cador M; Bjijou Y; Cailhol S; Stinus L
    Neuroscience; 1999; 94(3):705-21. PubMed ID: 10579562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Signalling through phospholipase C beta 4 is not essential for midbrain dopaminergic neuron survival.
    Smits SM; van der Nobelen S; Hornman KJ; von Oerthel L; Burbach JP; Smidt MP
    Neuroscience; 2005; 136(1):171-9. PubMed ID: 16198487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-opioid effects of neuropeptide FF receptors in the ventral tegmental area.
    Kersanté F; Wang JY; Chen JC; Mollereau C; Zajac JM
    Neurosci Lett; 2011 Jan; 488(3):305-9. PubMed ID: 21111027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The neurokinin-3 receptor (NK3R) antagonist SB222200 prevents the apomorphine-evoked surface but not nuclear NK3R redistribution in dopaminergic neurons of the rat ventral tegmental area.
    Hether S; Misono K; Lessard A
    Neuroscience; 2013 Sep; 247():12-24. PubMed ID: 23673279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Central neuronal pathways containing FLFQPQRFamide-like (morphine-modulating) peptides in the rat brain.
    Kivipelto L; Panula P
    Neuroscience; 1991; 41(1):137-48. PubMed ID: 2057058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dissociated high-purity dopaminergic neuron cultures from the substantia nigra and the ventral tegmental area of the postnatal rat.
    Masuko S; Nakajima S; Nakajima Y
    Neuroscience; 1992 Jul; 49(2):347-64. PubMed ID: 1359454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different neuronal location of [3H]SCH 23390 binding sites in pars reticulata and pars compacta of the substantia nigra in the rat.
    Savasta M; Dubois A; Benavides J; Scatton B
    Neurosci Lett; 1986 Dec; 72(3):265-71. PubMed ID: 2950341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opiate-induced motor stimulation is regulated by gamma-aminobutyric acid type B receptors found in the ventral tegmental area in mice.
    Leite-Morris KA; Fukudome EY; Kaplan GB
    Neurosci Lett; 2002 Jan; 317(3):119-22. PubMed ID: 11755254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Temporal and spatial increase of astroglial basic fibroblast growth factor synthesis after 6-hydroxydopamine-induced degeneration of the nigrostriatal dopamine neurons.
    Chadi G; Cao Y; Pettersson RF; Fuxe K
    Neuroscience; 1994 Aug; 61(4):891-910. PubMed ID: 7838386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distribution of neuropeptide FF (NPFF) receptors in correlation with morphine-induced reward in the rat brain.
    Wu CH; Tao PL; Huang EY
    Peptides; 2010 Jul; 31(7):1374-82. PubMed ID: 20381562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of cerebral lesions on binding sites for calcitonin and calcitonin gene-related peptide in the rat nucleus accumbens and ventral tegmental area.
    Masuo Y; Giscard-Dartevelle S; Bouizar Z; Rostène W
    J Chem Neuroanat; 1991; 4(4):249-57. PubMed ID: 1657037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Excitotoxic lesions of the prefrontal cortex reduce dopamine D1-like receptors in the ventral tegmental area.
    Dewar KM; Rompré PP; Stewart J; Warren RA
    Eur J Pharmacol; 1997 Oct; 336(2-3):155-8. PubMed ID: 9384227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Localization of 5-HT(2A) receptors on dopamine cells in subnuclei of the midbrain A10 cell group.
    Nocjar C; Roth BL; Pehek EA
    Neuroscience; 2002; 111(1):163-76. PubMed ID: 11955720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ventral mesencephalic neurons containing both cholecystokinin- and tyrosine hydroxylase-like immunoreactivities project to forebrain regions.
    Seroogy KB; Dangaran K; Lim S; Haycock JW; Fallon JH
    J Comp Neurol; 1989 Jan; 279(3):397-414. PubMed ID: 2563737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of ventral mesencephalic reticular formation and related noradrenergic and serotonergic bundles in turning behaviour as investigated by means of kainate, 6-hydroxydopamine and 5,7-dihydroxytryptamine lesions.
    Porceddu ML; Imperato A; Melis MR; Di Chiara G
    Brain Res; 1983 Mar; 262(2):187-200. PubMed ID: 6404501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemogenetic activation of dopamine neurons in the ventral tegmental area, but not substantia nigra, induces hyperactivity in rats.
    Boekhoudt L; Omrani A; Luijendijk MC; Wolterink-Donselaar IG; Wijbrans EC; van der Plasse G; Adan RA
    Eur Neuropsychopharmacol; 2016 Nov; 26(11):1784-1793. PubMed ID: 27712862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.